glp-1 receptor antagonist Science Behind GLP 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements Frontiers | GLP-1 receptor agonist

Changes in vision should be evaluated, particularly in patients with pre-existing diabetic retinopathy

And there was one study published this last year, talking about colon cancer and pretty significant reductions

Adding an extra week or two at each dose level allows the body more time to adapt

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)

Research into microneedle patch technology is underway to deliver real GLP-1 medications, but its still in the initial phases

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotics acetate and lactate which feed bacteria such as Akkermansia and Butyricum, promoting an ecosystem in the gut that supports a healthy gut lining and naturally boosts GLP-1